CIMETIDINE (cimetidine) by Teva is clinical pharmacology cimetidine competitively inhibits the action of histamine at the histamine h 2 receptors of the parietal cells and thus is a histamine h 2 -receptor antagonist. Approved for of symptoms. First approved in 1994.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Cimetidine competitively inhibits the action of histamine at the histamine H 2 receptors of the parietal cells and thus is a histamine H 2 -receptor antagonist. Cimetidine is not an anticholinergic agent. Studies have shown that cimetidine inhibits both daytime and nocturnal…
Worked on CIMETIDINE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Effect of Cimetidine on the PK of Imeglimin
Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects
Drug-drug Interaction Study of CHF5993 With Cimetidine
Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX